The selective C-H carbonylation of methylene bonds in the presence of traditionally more reactive methyl C-H and C(sp 2 )-H bonds in a-tertiary amines is reported. The exceptional selectivity is driven by the bulky a-tertiary amine motif, which we hypothesise orientates the activating C-H bond proximal to Pd in order to avoid an unfavourable steric clash with a second a-tertiary amine on the Pd centre, promoting preferential cyclopalladation at the methylene position. The reaction tolerates a range of structurally interesting and synthetically versatile functional groups, delivering the corresponding b-lactam products in good to excellent yields.
a fully substituted carbon atom on one side of the amine linkage, which steers the reaction to the C-H bond adjacent to this bulky structural feature (Scheme 1c). Herein, we report the development of a general C-H carbonylation exploiting this selectivity-inducing parameter. The ATA motif is widespread among natural products and pharmaceuticals displaying unique physiochemical properties (Scheme 2).
11 However, due to the limited number of methods available in accessing these compounds, we believe that the direct functionalization of ATAs would provide convenient access to a range of molecular scaffolds that would be attractive to practitioners of synthetic and medicinal chemistry.
Using the conditions developed for methylene C-H carbonylation, 9 using xantphos as a ligand, 12 we rst assessed substrates displaying a variety of substituents in the a-position on the reacting side of the amine linkage; the secondary amines also contained a b-methyl C-H bond (in the form of an N-ethyl group) on the other side of the free (NH) motif (Table 1) . Substrates containing protected a-hydroxymethylene substituents proved effective under the reaction conditions, delivering the fused bicyclic b-lactams (2a and 2b) resulting from selective methylene C-H carbonylation in good yields. 13 Moreover, an a-n-butyl chain was also sufficient to deliver the corresponding bicyclic b-lactam 2c in 59% yield, remarkably without any activation of the exocyclic a-alkyl substituent, which contains a competitive methylene b-C-H bond. Exclusive methylene C-H activation also occurred on the corresponding acyclic substrate 1d, further expanding the utility of the methodology. The corresponding N-isopropyl substrate 1e, for which there is a 6 : 4 ratio of methyl to methylene C-H bonds, afforded a 1.5 : 1 mixture of b-lactams in favour of the methylene C-H activated product, exemplifying the remarkable selectivity inherent to this C-H activation process.
We hypothesize that the selectivity of this methylene C-H carbonylation process arises from the unique Pd(II)-carboxamide intermediate (pathways A and B, Scheme 3) . Based on our previous work, 7 we propose that a key hydrogen-bond between the carboxamide carbonyl and ligated amine locks the relative conformation of these two substituents, in turn generating two potentially reactive carboxamide intermediates (int-I and int-II). We believe that the large a-tertiary amine substituent generates an unfavorable steric clash with the ligated amine (int-II), resulting in preferential activation of the highlighted methylene C-H bond (pathway A).
14 While this model holds for the majority of the substrates, we believe that the large isopropyl amine substituent in amine 1e may result in poorer steric differentiation between the two Pd-carboxamide transition states, leading to the formation of both methylene and methyl activated products (Table 1) .
Having successfully demonstrated that a fully substituted centre in the a-position to the amine is sufficient to induce exclusive b-methylene C-H activation, we next explored how substituents on the non-reacting side of the amine affected the carbonylation process (Table 2 ). The competing classical 5-membered cyclopalladation was not observed in n-propylcontaining amine 2g or n-heptyl amine 2f, affording the corresponding bicyclic b-lactams in a 66% and 70% yield respectively. b-Amino ester 2h and sulfone 2i derivatives bearing acidic a-hydrogens, which have previously been shown to promote C-H activation, 9 were tolerated in good yield and on gram scale. The use of Lewis basic heteroaromatics, such as pyridyl motifs, to direct C(sp 3 )-H activation is well established. 5c,15 An amine displaying 2-pyridyl substituent 1j was tolerated in good yield, with no competitive C-H activation on the propyl chain. Impressively, bis-cyclohexyl substrate 1k, bearing two very similar sets of methylene C-H bonds, afforded a single b-lactam 2k with activation occurring exclusively in the a-position to the quaternary carbon centre.
Having established the robustness of this methodology towards a range of functional groups, we turned our attention to substrates containing N-methyl amines (Table 3) . Despite the ubiquity of N-Me amines in biologically active molecules and pharmaceutical agents, their deleterious reactivity with many electrophilic transition metal catalysts has rendered them challenging substrates for C-H activation.
16 The facile oxidation of N-methylamines to the corresponding imine followed by nucleophilic capture has been exploited in numerous transformations.
17 Due to the high pharmaceutical utility of Nmethylamines, 18 we sought to test the limits of our C-H activation methodology by investigating this important class of amine substrate. By virtue of our geometrically locked Pdcarboxamide intermediate, we reasoned that the N-methyl group would be placed in a remote position relative to the reactive palladium centre, thereby enabling a selective process.
As a control experiment, N-methylcyclohexylamine 1l, lacking the important fully substituted a-tertiary centre, was subjected to our optimized conditions; none of the desired blactam product was observed and the starting amine decomposed. In line with our hypothesis, a-tertiary amino-alcohol derivatives 1m and 1n delivered the corresponding b-lactams (2m-n) in good yield without any demethylation. Piperidine and tetrahydropyran motifs are common among pharmaceutical agents but their functionalization at C3 and C4 positions can present a signicant challenge;
19 our methodology delivered the bicyclic b-lactam products 2o and 2q in good yields, allowing for further derivatization of the C3 position. The reaction also proved to be tolerant of a thioether moiety, known to deactivate transition metal catalysts, delivering the b lactam 2p in a good 84% yield. Moreover, the reaction proved extremely versatile across a range of ring sizes (2t to 2w) in good yield. Pleasingly, cyclobutylamine 1v was readily transformed into highly strained 4,4-fused b-lactam 2v, permitting access to functionalized hydrogenated variants of the 'Dewar-pyridone' scaffold.
20
To test the limits of the positional selectivity of the ATA carbonylation among many potentially reactive C-H bonds, we prepared a range of functional amines that could lead to a number of different lactam products (Scheme 4). Indole rings are considered a "privileged" scaffold in medicinal chemistry, 21 however, they oen undergo facile C(sp 2 )-H activation. 22 We were pleased to observe that tryptamine analogue 1x bearing a cyclobutane ring was readily transformed into the 4,4-fused b-lactam 2x in good yield without any competing C(sp 2 )-H activation. 3-Methylamino piperidine 1y, containing two different ring C-H bond environments, afforded complete selectivity for the C4 position in useful yield (2y). Similarly, the 2-aminotetralin substrate 1z proved to activate selectively at the benzylic position in good yield, revealing a class of tricyclic b-lactam scaffolds (2z).
To challenge the capacity of the selective C-H carbonylation process, we next designed a substrate that would place a b-methylene C-H bond in competition with a C(sp 2 )-H bond on the ortho position of a benzylamine motif. The cyclopalladation of benzylamines is, arguably, one of the most facile and well understood C-H activation processes, with near exclusive C(sp 2 )-H activation control. 23 Orito and coworkers have shown that alkyl-benzyl substituted secondary amines undergo selective C(sp 2 )-H carbonylation to benzolactams, with no trace of reaction at the C(sp 3 )-H bond (Scheme 5a). 24 To benchmark the reactivity of our alkyl-benzyl amines, we applied Orito's conditions to N-benzyl amine derivative 1aa and found that benzolactam 3aa resulting from C(sp 2 )-H activation was produced as the sole product (Scheme 5a). Upon switching to our optimized C-H carbonylation conditions, we were delighted to see that a mixture of b-lactam 2aa and benzolactam 3aa was formed in a good 83% yield with a 2.2 : 1 ratio in favor of the C(sp 3 )-H activation product 2aa
(Scheme 5b). Encouragingly, we found that changing the electronic properties of the aromatic ring had a signicant impact an electrophilic cyclopalladation pathway. To the best of our knowledge, this is the rst example of a palladium catalyzed C-H activation that is selective for a b-methylene C-H bond in the presence of a g-C(sp 2 )-H bond on an aromatic ring.
Finally, we transformed the b-lactam products into a range of useful chemical building blocks (Scheme 6). Alkylation to form b-lactams displaying vicinal fully substituted stereocenters proceeded in good yield (4a). Reduction of 2n to the corresponding azetidinyl alcohol 4b, a useful class of scaffold in the design of pharmaceutical agents, occurred in an excellent 90% yield. Importantly, the free (NH)lactam 4c could be obtained in good yield under mild conditions from the corresponding sulfonyl blactam 2h, offering a simple lactam deprotection protocol.
In conclusion, we have developed a remarkable aliphatic amine C-H carbonylation reaction that is capable of selectively activating b-methylene C-H bonds in the presence of traditionally more reactive C(sp 3 ) and C(sp 2 )-H bonds. The presence of a fully substituted carbon atom in the a-position to the amine appears to control this unprecedented selectivity. Using this methodology, a range of highly functionalized b-lactam building blocks have been synthesized in good yields, which can further be derivatised in order to access novel heterocyclic scaffolds that we believe we be useful to a range of synthetic and medicinal applications. Computational studies to explore the origin of this unique selectivity in further detail are currently ongoing within our group.
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